The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
GM-CSF Upregulated in Rheumatoid Arthritis Reverses Cognitive Impairment and Amyloidosis in Alzheimer Mice
Open accessAbstract
Rheumatoid arthritis (RA) is a negative risk factor for the development of Alzheimer's disease (AD). While it has been commonly assumed that RA patients' usage of non-steroidal anti-inflammatory drugs (NSAIDs) helped prevent onset and progression of AD, NSAID clinical trials have proven unsuccessful in AD patients. To determine whether intrinsic factors within RA pathogenesis itself may underlie RA's protective effect, we investigated the activity of colony-stimulating factors, upregulated in RA, on the pathology and behavior of transgenic AD mice. 5 microg bolus injections of macrophage, granulocyte, and granulocyte-macrophage colony-stimulating factors (M-CSF, G-CSF, or GM-CSF) were administered unilaterally into the hippocampus of aged cognitively-impaired AD mice and the resulting amyloid load reductions determined one week later, using the artificial cerebrospinal fluid-injected contralateral sides as controls. G-CSF and more significantly, GM-CSF reduced amyloidosis throughout the treated brain hemisphere one week following bolus administration to AD mice. 20 daily subcutaneous injections of 5 microg of GM-CSF (the most amyloid-reducing CSF in the bolus experiment) were administered to balanced cohorts of AD mice after assessment in a battery of cognitive tests. Reductions in amyloid load and improvements in cognitive function were assessed. Subcutaneous GM-CSF administration significantly reduced brain amyloidosis and completely reversed the cognitive impairment, while increasing hippocampal synaptic area and microglial density. These findings, along with two decades of accrued safety data using Leukine, recombinant human GMCSF, in elderly leukopenic patients, suggest that Leukine should be tested as a treatment to reverse cerebral amyloid pathology and cognitive impairment in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, the levels of antiageing factors, such as GDF11, tissue inhibitor of metalloproteinase 2 (TIMP2) and granulocyte‒macrophage colony stimulating factor (CSF2), are reduced. These factors are linked to improved microglial phagocytosis and neurogenesis and reduce the Aβ load, thus enhancing cognition.72,322–324”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [323]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 2×
“4), implying an augmentedability to bind and removeamyloid deposition [27,28].”
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Wu, H., Liu, X., Jaenisch, R., & Lodish, H. F. (1995) · Cell · doi:10.1016/0092-8674(95)90234-1 · Cited by 1,007
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987
El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Self-citationErythropoietin: Physiology and Pharmacology Update
Fisher, J. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800101 · Cited by 707
CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens
Helmy, K. Y., Katschke, K. J., Gorgani, N. N., Kljavin, N. M., Elliott, J. M., Diehl, L. J., Scales, S. J., Ghilardi, N., & Campagne, M. V. L. (2006) · Cell · doi:10.1016/j.cell.2005.12.039 · Cited by 629
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162350199 · Cited by 446
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.
(1994) · PubMed Central · Cited by 441
Simard, A. R., & Rivest, S. (2004) · The FASEB Journal · doi:10.1096/fj.04-1517fje · Cited by 362
Arendash, G. W., King, D. L., Gordon, M. N., Morgan, D., Hatcher, J. M., Hope, C. E., & Diamond, D. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03186-3 · Cited by 349
Self-citationMacrophages and their products in rheumatoid arthritis
Szekanecz, Z., & Koch, A. E. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32805e87ae · Cited by 309
Malm, T. M., Koistinaho, M., Pärepalo, M., Vatanen, T., Ooka, A., Karlsson, S., & Koistinaho, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.009 · Cited by 301
Clinicopathologic Studies of Primary Cerebral Amyloid Angiopathy
Okazaki, H., Reagan, T. J., & Campbell, R. J. (1979) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)18993-3 · Cited by 259
Xu, W., Firestein, G. S., Taetle, R., Kaushansky, K., & Zvaifler, N. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113971 · Cited by 258
Amoura, Z., Koutouzov, S., Chabre, H., Cacoub, P., Amoura, I., Musset, L., Bach, J., & Pietté, J. C. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1 · Cited by 243
Inflammation, anti-inflammatory agents and Alzheimer disease: The last 12 years
McGeer, P. L., Rogers, J., & McGeer, E. G. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s330 · Cited by 222
Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., & Rivest, S. (2008) · Brain · doi:10.1093/brain/awn331 · Cited by 221
Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes
Rogers, J., Li, R., Mastroeni, D., Grover, A., Leonard, B., Ahern, G., Cao, P., Kolody, H., Vedders, L., Kolb, W. P., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.043 · Cited by 175
Schäbitz, W.-R., Krüger, C., Pitzer, C., Weber, D., Laage, R., Gaßler, N., Aronowski, J. A., Mier, W., Kirsch, F., Dittgen, T., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600496 · Cited by 168
Sanchez‐Ramos, J., Song, S., Sava, V. M., Catlow, B. J., Lin, X., Mori, T., Cao, C., & Arendash, G. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.071 · Cited by 165
Self-citationG-CSF rescues the memory impairment of animal models of Alzheimer's disease
Tsai, K., Tsai, Y.-C., & Shen, C.-K. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062481 · Cited by 155
Koenigsknecht-Talboo, J., Meyer-Luehmann, M., Parsadanian, M., Garcia-Alloza, M., Finn, M. B., Hyman, B. T., Bacskai, B. J., & Holtzman, D. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4147-08.2008 · Cited by 149
Emerson, S., Sieff, C. A., Wang, E. A., Wong, G. G., Clark, S., & Nathan, D. G. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112087 · Cited by 144
Padmanabhan, J., Levy, M. M., Dickson, D. W., & Potter, H. (2006) · Brain · doi:10.1093/brain/awl255 · Cited by 124
Self-citationLoewenstein, D., Acevedo, A., Luis, C. A., Crum, T. A., Barker, W., & Duara, R. (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704101112 · Cited by 122
McLay, R. N. (1997) · Brain · doi:10.1093/brain/120.11.2083 · Cited by 109
Parsonage, G. N., Filer, A. D., Bik, M., Hardie, D. L., Lax, S., Howlett, K. A., Church, L. D., Raza, K., Wong, S. H., Trebilcock, E., et al. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2406 · Cited by 93
Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation
Nilsson, L. N. G., Arendash, G. W., Leighty, R. E., Costa, D. A., Low, M. A., Garcia, M. F., Cracciolo, J. R., Rojiani, A. M., Wu, X., Bales, K. R., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.011 · Cited by 88
Self-citationPotter, H. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00308-6 · Cited by 87
Self-citationEcheverrı́a, V., Burgess, S., Gamble‐George, J., Zeitlin, R., Lin, X., Cao, C., & Arendash, G. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.019 · Cited by 70
Self-citationBoth Th1 and Th17 Are Immunopathogenic but Differ in Other Key Biological Activities
Cox, C. A., Shi, G., Yin, H., Vistica, B. P., Wawrousek, E. F., Chan, C., & Gery, I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7414 · Cited by 68
Nakamura, H., Ueki, Y., Sakito, S., Matsumoto, K., Yano, M., Miyake, S., Tominaga, T., Tominaga, M., & Eguchi, K. (2000) · PubMed · Cited by 55
Krüger, C., Laage, R., Pitzer, C., Schäbitz, W., & Schneider, A. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-88 · Cited by 54
Schneider, U. C., Schilling, L., Schroeck, H., Nebe, C. T., Vajkoczy, P., & Woitzik, J. (2007) · Stroke · doi:10.1161/01.str.0000259707.43496.71 · Cited by 51
Regulation of Tau Phosphorylation in Alzheimer's Disease
Lee, V. M. ‐. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34408.x · Cited by 46
Kirma, N. B., Luthra, R., Jones, J., Liu, Y.-G., Nair, H. B. B., Mandava, U., & TEKMAL, R. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2971 · Cited by 43
Reddy, P., Mańczak, M., Zhao, W., Nakamura, K., Bebbington, C., Yarranton, G., & Mao, P. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06432.x · Cited by 33
Macrophage colony-stimulating factor in patients with rheumatoid arthritis.
Kawaji, H., Yokomuro, K., Kikuchi, K., Somoto, Y., & Shirai, Y. (1995) · Journal of Nippon Medical School · doi:10.1272/jnms1923.62.260 · Cited by 29
Bennett, S. P., Boyd, T. D., Norden, M., Padmanabhan, J., Neame, P. J., Wefes, I., & Potter, H. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.08.021 · Cited by 5
Self-citationStraub, R. H., & Cutolo, M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3
Cited by
Sorted by citations
Human umbilical cord plasma proteins revitalize hippocampal function in aged mice
Castellano, J. M., Mosher, K. I., Abbey, R. J., McBride, A. A., James, M. L., Berdnik, D., Shen, J. C., Zou, B., Xie, X. S., Tingle, M., et al. (2017) · Nature · doi:10.1038/nature22067 · Cited by 445
Dupuis-Maguiraga, L., Noret, M., Brun, S., Grand, R. L., Gras, G. S., & Roques, P. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001446 · Cited by 317
Microglia actions in Alzheimer's disease
Prokop, S., Miller, K. R., & Heppner, F. L. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1182-x · Cited by 291
Peripheral immune system in aging and Alzheimer’s disease
Cao, W., & Zheng, H. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0284-2 · Cited by 214
The immunology of neurodegeneration
Czirr, E., & Wyss‐Coray, T. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58656 · Cited by 218
Metadata
- Authors
- Boyd, T. D., Bennett, S. P., Mori, T., Governatori, N., Runfeldt, M., Norden, M., Padmanabhan, J., Neame, P., Wefes, I., Sanchez-Ramos, J., Arendash, G. W., & Potter, H.
- Affiliations
- University of South Florida (US)
- Social Insurance Saitama Chuo Hospital (JP)
- USF Health Byrd Alzheimer's Center and Research Institute, Tampa, FL, USA
- Corresponding author
- Potter, Huntington
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-08-11
- Volume
- 21
- Issue
- 2
- Pages
- 507-518
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC5588158
- OpenAlex
- W2142301391
- Cited by
- 128
- References
- 46
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 12 · 2023: 4 · 2022: 10 · 2021: 9 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 8 · 2016: 11 · 2015: 6 · 2014: 5 · 2013: 6 · 2012: 14
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons - University of South Florida (University of South Florida) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (22500320)
- National Institute on Aging (P50 AG25711, P50AG025711)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- rheumatoid arthritis, Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Amyloidosis, Animals, Arthritis, Rheumatoid, Cognition Disorders, Disease Models, Animal, Hippocampus, Humans, Mice, Inbred C57BL, Mice, Transgenic, Risk Factors, Up-Regulation, Macrophage Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor, Granulocyte Colony-Stimulating Factor, Maze Learning, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
